Pericancerous cross-presentation to cytotoxic T lymphocytes impairs immunotherapeutic efficacy in hepatocellular carcinoma.
Huang CX, Lao XM, Wang XY, Ren YZ, Lu YT, Shi W, Wang YZ, Wu CY, Xu L, Chen MS, Gao Q, Liu L, Wei Y, Kuang DM.
Huang CX, et al. Among authors: wang xy, wang yz.
Cancer Cell. 2024 Dec 9;42(12):2082-2097.e10. doi: 10.1016/j.ccell.2024.10.012. Epub 2024 Nov 14.
Cancer Cell. 2024.
PMID: 39547231